FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: The potential approval of Moderna's mRNA flu vaccine could influence pharmaceutical and biotechnology research and development efforts within Rhode Island, particularly given the state's academic institutions and emerging bioscience sector.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.